TL;DR

A group of more than 20 British firms, the Drystone Health AI Collaboration, intends to compete for the FDP, the NHS’s £330m Federated Data Platform contract currently held by Palantir, Digital Health reported on 17 November. London data firm Quantexa is believed to be readying its own bid, and Oracle Health is seen as a possible contender.

Two members, Black Pear Software and Voror Health Technologies, bid for the FDP in 2023. Others include IMS Maxims, Interweave Digital, Patients Know Best and VitalHub UK. It was founded by Shane Tickell, who runs the health consultancy Temple Black.

Why a contest may open up

Palantir’s contract started in March 2024 for three years, with options to extend for up to four more. Campaigners, patients and clinicians want it ended when the break clause falls in March 2027, citing concerns about the company’s ethics, doubts about the benefits claimed for the FDP and reliance on US suppliers.

Digital Health points to reports this month that ministers intend a two-year extension of the current deal, to keep services stable, while they design a new tender that would suit British suppliers better. It also cites FT reporting that the government is working on what should count as a UK supplier in procurement, and that Palantir could point to its UK-based workforce to keep the work.

What the bidders are saying

Lisa Riley, VitalHub’s UK strategy lead, said the effort “shouldn’t just be about competing with Palantir” but about proving British firms hold much of the talent and technology “needed to build what comes next”. Riley has previously told Digital Health that the FDP’s Midlands regional coordination centre took the place of VitalHub’s SHREWD system, which she argues did more.

Neill McAnaspie of IMS Maxims said the group could speed up “responsible innovation, including AI”. Drystone says it is aiming beyond the 10-year health plan’s goals, which cover frontline productivity, the FDP and a single record for each patient.

Looking forward

The FDP has been a recurring flashpoint, most recently when NHS England removed a published list of 137 trusts it said were benefiting from Palantir. In our view, a joint British bid gives ministers a domestic alternative to weigh against Palantir, and the government’s test of what counts as a British supplier will decide how much weight a bid like Drystone’s carries. If the reported two-year extension goes ahead, that contest would come after the 2027 break point rather than at it.